VIP943
Hematologic Malignancies (e.g., AML)
Phase 1Active
Key Facts
About Vincerx Pharma
Vincerx Pharma is dedicated to accelerating the development of life-changing medicines for cancer patients with high unmet needs. The company employs a capital-efficient, virtual R&D model to advance a diverse pipeline of small molecules and biologics, including both proprietary and in-licensed assets. Its strategy focuses on strategic partnerships and targeted clinical development to maximize the potential of its oncology portfolio. Vincerx aims to address significant market opportunities in oncology through precision medicine approaches.
View full company profileTherapeutic Areas
Other Hematologic Malignancies (e.g., AML) Drugs
| Drug | Company | Phase |
|---|---|---|
| CD33 Shielding Platform | Cimeio Therapeutics | Pre-clinical |